Delivery Order SPE2DB20D1004-SPE2DB24FF4E0
- Not listed
- This federal contract award is for the delivery of Humira (CF) Pen 40 mg/0.4 mL to the Defense Logistics Agency (DLA), a defense agency under the Department of Defense (DoD). The $3,928.62 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distributor. The contract has an ultimate completion date of March 8, 2022. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
- This federal contract award is for the delivery of Humira (CF) Pen 40 mg/0.4 mL, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $5,357.92 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of August 22, 2023 and was awarded on August 21, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
- This federal contract award is for the delivery of Humira (CF) Pen 40 mg/0.4 mls to the Defense Logistics Agency (DLA). The $1,385.37 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor that is a subsidiary of Cencora, Inc. The contract has an ultimate completion date of January 26, 2024 and was awarded on January 25, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- The federal contract award is for the delivery of Humira (CF) Pen 40 mg/0.4 mL pharmaceutical products to the Defense Logistics Agency (DLA) under a Firm Fixed Price Delivery Order. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, valued at $12,944.56. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical...
- This federal contract award is for the delivery of Humira(CF) Pen 40 mg/0.4 mls, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical program. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., a major pharmaceutical distribution company. The contract has a ceiling value of $17,564.47 and an ultimate completion date of November 2, 2023. This is a delivery order contract with a firm fixed-price pricing...
- This federal contract award is for the delivery of Humira (CF) Pen 40 mg/0.4 mL to the Defense Logistics Agency (DLA). The contract, valued at $7,580.06, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on May 20, 2024. This is a delivery order contract with a firm fixed price pricing type, and the ultimate completion date is May 21, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC)...
- This federal contract award is for the delivery of Humira (CF) Pen 40 mg/0.4 mL pharmaceutical products to the Defense Logistics Agency (DLA). The $5,486.46 Firm Fixed Price contract was awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceuticals and medical supplies to the U.S. government. Amerisourcebergen holds a single-award Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 2025. This...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Humira (CF) Pen 40 mg/0.4 mls pharmaceutical products. The contract, valued at $3,523.38, was awarded by the Defense Logistics Agency (DLA) on October 30, 2023, with an ultimate completion date of October 31, 2023. The contract is a Delivery Order under a Firm Fixed Price pricing type. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, holds a significant Indefinite...
- This federal contract award is to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of Humira (CF) Pen 40 mg/0.4 mL. The contract, valued at $2,770.74, was awarded by the Defense Logistics Agency (DLA) and has a completion date of February 12, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive...
- This federal contract award is for the delivery of Humira(CF) Pen 40 mg/0.4 mLs pharmaceutical products to the Defense Logistics Agency (DLA). The $3,523.38 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has a completion date of November 15, 2023 and does not utilize any set-aside designations. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- SPE2DB20D1004Indefinite Delivery Contract
- SPE2DB20D1004-SPE2DB24FF4E0Delivery Order
This federal contract award is for the delivery of Humira (CF) Pen 40 mg/0.4 mL, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $4,462.16, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a Firm Fixed Price Delivery Order with a performance period ending on February 15, 2024. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs. This delivery order is issued under that IDC. The contract does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.5k | 2/14/24 |